Is low-molecular-weight heparin superior to aspirin for VTE prophylaxis?

J Fam Pract. 2023 Nov;72(9):E14-E16. doi: 10.12788/jfp.0698.

Authors

Matthew Rose¹, Nilmini Pang¹, Sara Conway¹

Affiliation

¹ University of Tennessee, Chattanooga Family, Medicine Residency Program.

PMID: 37976336
DOI: 10.12788/jfp.0698

Abstract

Aspirin demonstrated a significantly higher rate of postoperative venous thromboembolic events compared with enoxaparin in this noninferiority study.

MeSH terms

Anticoagulants / therapeutic use
Aspirin / therapeutic use
Enoxaparin / therapeutic use
Heparin
Heparin, Low-Molecular-Weight* / therapeutic use
Humans
Venous Thromboembolism* / drug therapy
Venous Thromboembolism* / prevention & control

Substances

Heparin, Low-Molecular-Weight
Aspirin
Anticoagulants
Enoxaparin
Heparin